Neurological disorders: the fastest‑growing frontier in drug discovery
Alzheimer's, Parkinson's, ALS — these diseases have been notoriously hard to treat. But small molecules are making a comeback. The small molecule drug discovery market research shows that neurological disorders are the fastest‑growing therapeutic area, with a CAGR above 10%. Why? Because new targets (tau, alpha‑synuclein) are being validated, and AI is helping design molecules...
0 Comments 0 Shares 4 Views 0 Reviews
MakeMyFriends https://makemyfriends.com